Key result
Cycle-dependent variation of myocardial integrated backscatter at the left ventricular posterior wall was a powerful independent predictor of cardiac and all-cause death (P<0.0001).
Why the study?
Does cycle-dependent variation of myocardial integrated backscatter (CV-IB) predict mortality in patients with primary cardiac amyloidosis?
Cohort (n=208)
Does cycle-dependent variation of myocardial integrated backscatter (CV-IB) predict mortality in patients with primary cardiac amyloidosis?
CV-IB at the LV posterior wall is a powerful independent predictor of clinical outcome in patients with cardiac amyloidosis, superior to standard echocardiographic/Doppler flow indexes.
Answers are grounded in this paper and cite their sources.
CV-IB may support prognosis in cardiac amyloidosis; leaves open incremental value over standard echo indexes pending validation.
BACKGROUND: Cycle-dependent variation of myocardial integrated backscatter (CV-IB) is an objective measurement that may detect myocardial abnormalities. However, no data exist about the prognostic value of CV-IB in primary cardiac amyloidosis. METHODS AND RESULTS: We prospectively examined 208 consecutive biopsy-proven patients with primary amyloidosis. The magnitude of CV-IB was analyzed at the interventricular septum and left ventricular (LV) posterior wall and its prognostic value was compared with standard Doppler measurements with to the Tei index (isovolumic contraction time plus isovolumic relaxation time divided by ejection time). One hundred thirty-three patients had cardiac involvement (mean LV thickness > 12 mm). Forty-one patients (20%) (32 cardiac deaths) died during a mean follow-up of period of 307+/-156 days. Univariate analysis showed that the CV-IB at the LV posterior wall was the best predictor of cardiac death (P<0.0001) and all-cause death (P< 0.0001). The Tei index did not identify patients at risk of death. Multivariate analysis showed that CV-IB at the LV posterior wall was the only independent predictor of both cardiac and overall deaths. CONCLUSIONS: Among patients with cardiac amyloidosis, CV-IB at the LV posterior wall is a powerful predictor of clinical outcome and is superior to standard echocardiographic/Doppler flow indexes.
No takes yet. Share an insight, caveat, or question.
Koyama et al. (2002) conducted a cohort in primary cardiac amyloidosis (n=208). Cycle-dependent variation of myocardial integrated backscatter (CV-IB) vs. Standard Doppler measurements (Tei index) was evaluated on cardiac death and all-cause death (p=<0.0001). Cycle-dependent variation of myocardial integrated backscatter at the left ventricular posterior wall was a powerful independent predictor of cardiac and all-cause death (P<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: